Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and …
L Da Silva, T Klopfenstein, V Gendrin, J Clouet, L Toko… - Viruses, 2023 - mdpi.com
We highlighted in this current paper similar prolonged respiratory presentation with COVID-
19 pneumonia in four severely immunocompromised patients currently being treated with …
19 pneumonia in four severely immunocompromised patients currently being treated with …
Monitoring of adaptive immune responses in healthcare workers who received a Coronavirus disease 2019 vaccine booster dose
C Klinmalai, S Srisala, T Sahakijpicharn… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aims Coronavirus disease 2019 (COVID‐19) has become a global
pandemic and led to increased mortality and morbidity. Vaccines against the etiologic agent; …
pandemic and led to increased mortality and morbidity. Vaccines against the etiologic agent; …
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: A Randomised, Comparator-Controlled …
VD Thiem, DD Anh, VH Ha, NV Thom, TC Thang… - medRxiv, 2023 - medrxiv.org
Background Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low-
and lower-middle-income countries is needed. NDV-HXP-S is an inactivated egg-based …
and lower-middle-income countries is needed. NDV-HXP-S is an inactivated egg-based …
Incidence of Severe COVID-19 Outcomes and Immunization Rates in Apulian Individuals with Inflammatory Bowel Disease: A Retrospective Cohort Study
FP Bianchi, A Contaldo, MG Polignano, A Pisani - Vaccines, 2024 - mdpi.com
The etiology of Inflammatory Bowel Disease (IBD) is not fully understood but is believed to
involve a dysregulated immune response to intestinal microbiota in genetically susceptible …
involve a dysregulated immune response to intestinal microbiota in genetically susceptible …
Immune response variation in mild and severe COVID-19 patients
S Stroz, P Kosiorek, E Zbroch, B Mikoluc… - Qatar Medical …, 2024 - qscience.com
Sixty patients with COVID-19 infection were categorized into mild and severe groups, and
their immune response was analyzed using flow cytometry and complete blood count. An …
their immune response was analyzed using flow cytometry and complete blood count. An …
QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: A Systematic Review and Meta …
MM Dourdouna, G Kourlaba, A Michos - 2024 - researchsquare.com
A systematic review and meta-analysis was performed to evaluate the virus-specific T-cell
response after COVID-19 mRNA vaccination, using the QuantiFERON-SARS-CoV-2 …
response after COVID-19 mRNA vaccination, using the QuantiFERON-SARS-CoV-2 …
[PDF][PDF] Identification of mouse CD4 T
L Bricio-Moreno, JB de Albuquerque, JM Neary… - 2024 - scienceopen.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen
of the coronavirus disease 2019 (COVID-19) pandemic that has become an epic global …
of the coronavirus disease 2019 (COVID-19) pandemic that has become an epic global …
[HTML][HTML] The predicting value of circular DNA particles of T-and B-cell receptors for the dismal acute period outcomes and the disease severity of COVID-19 infection
TA Elistratova, EP Tikhonova, AA Savchenko… - Cytokines and …, 2023 - ter-arkhiv.ru
The pandemic of the new coronavirus infection COVID-19, caused by the SARS-CoV-2
virus, continues to be a serious problem for the entire global community. Currently, most …
virus, continues to be a serious problem for the entire global community. Currently, most …
[PDF][PDF] Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA. 1 spike and nucleocapsid for use in peptide: MHCII tetramers
EO Saphire, AD Luster, JJ Moon - scienceopen.com
Understanding adaptive immunity against SARS-CoV-2 is a major requisite for the
development of effective vaccines and treatments for COVID-19. CD4+ T cells play an …
development of effective vaccines and treatments for COVID-19. CD4+ T cells play an …